Eupraxia Pharmaceuticals Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $12.5M |
| FY2022 | $11.9M | $19.1M | $18.3M |
| FY2023 | $19.4M | $20.3M | $19.3M |
| FY2024 | $3.1M | $34.9M | $33.1M |
| FY2025 | $5.7M | $86.2M | $80.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $12.5M |
| FY2022 | $11.9M | $19.1M | $18.3M |
| FY2023 | $19.4M | $20.3M | $19.3M |
| FY2024 | $3.1M | $34.9M | $33.1M |
| FY2025 | $5.7M | $86.2M | $80.6M |